Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
August 2, 2024BMC CancerOpen Access

Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

RLRenyu LiuTYTing YangJHJinyu Huang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liu et al. (2024) studied this question.

synapsesocial.com/papers/68e5dae8b6db643587570ae0https://doi.org/10.1186/s12885-024-12712-w
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Advancing bladder cancer management: development of a prognostic model and personalized therapy2024 · 7 citations
  2. 2A novel prognostic model based on CD8+T cell infiltration-associated differentially expressed genes and immune-related genes predicts survival in bladder cancer2026
  3. 3Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer2026
  4. 4Identification and Validation of Prognostic Model for Tumor Microenvironment-Associated Genes in Bladder Cancer Based on Single-Cell RNA Sequencing Data Sets2024 · 5 citations
  5. 5Identification of bladder cancer subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes2024 · 4 citations